Home World BRIEF-Ultragenyx Announces The Publication Of A Successful 96-Week Randomized, Placebo-Controlled Trial With Crossover Treatment Of Genglycos™ (Also Known As Dtx401) Aav Gene Therapy In Gsdia In The Journal Of Inherited Metabolic Disease

BRIEF-Ultragenyx Announces The Publication Of A Successful 96-Week Randomized, Placebo-Controlled Trial With Crossover Treatment Of Genglycos™ (Also Known As Dtx401) Aav Gene Therapy In Gsdia In The Journal Of Inherited Metabolic Disease

BRIEF-Ultragenyx Announces The Publication Of A Successful 96-Week Randomized, Placebo-Controlled Trial With Crossover Treatment Of Genglycos™ (Also Known As Dtx401) Aav Gene Therapy In Gsdia In The Journal Of Inherited Metabolic Disease

Written By:
Published: September 2, 2026 01:44:12 IST

Add NewsX As A Trusted Source

Sept 1 (Reuters) – Ultragenyx Pharmaceutical Inc. : * ULTRAGENYX ANNOUNCES THE PUBLICATION OF A SUCCESSFUL 96-WEEK RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH CROSSOVER TREATMENT OF GENGLYCOS™ (ALSO

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

BRIEF-Albany International Announces Successful Completion Of Its Strategic Review And Schedules Investors Call

GRAINS-Chicago wheat hits multi-year peak after Russia rejects Black Sea grain plan

Soccer-South Africa unveil Mosimane as new coach ahead of qualifiers

BRIEF-Meta Superintelligence Labs Launching Muse Voice Transcribe

Packers GM: Team paused as process unfolds with RB Josh Jacobs

LATEST NEWS

Oracle licensing practices on EU antitrust regulator's radar, source says

Messi gets a milanese farewell at an Argentine restaurant

OpenAI says upcoming model is so capable it requires stronger guardrails

Dell again lifts forecasts as AI demand powers record results

BRIEF-Ultragenyx Announces The Publication Of A Successful 96-Week Randomized, Placebo-Controlled Trial With Crossover Treatment Of Genglycos™ (Also Known As Dtx401) Aav Gene Therapy In Gsdia In The Journal Of Inherited Metabolic Disease

OpenAI says upcoming model is so capable it requires stronger guardrails

Wall Street ends lower as higher yields, rising oil prices mark shaky start to September

'Milamessi': Argentine restaurant cooks up tribute to retiring soccer great

Amazon's Zoox, Alphabet's Waymo expand robotaxi services to more US cities

Amazon's Zoox, Alphabet's Waymo expand robotaxi services to more US cities

Follow Us

NewsX is India’s fastest growing English News Channel and enjoys highest viewership and highest time spent amongst educated urban Indians.

TOP CATEGORIES

QUICK LINKS

Follow Us

NewsX is India’s fastest growing English News Channel and enjoys highest viewership and highest time spent amongst educated urban Indians.

TOP CATEGORIES

Group Websites

QUICK LINKS